Shanghai Zhiyu Biotechnology provides AI-supported protein analysis, design, and research services.
Established in Shanghai in 2021, Shanghai Zhiyu Biotechnology provides protein structure prediction, design, and production services for drug research and synthetic biology. Its tools include ZCloud, ZPod, and ZBot. In May 2023, it raised over CNY 100 million in Series A funding led by Hongjia Asset Management, with participation from Hangzhou Qiantang Zhiyong Venture Capital Partnership (Limited Partnership), HM Capital, and Hongfeng Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Shanghai Zhiyu Biotechnology Co., Ltd.? This is my company